US EditionAstraZeneca Agrees to Pay $51M in Pay-for-Delay Lawsuit
Summary by News.law
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
AstraZeneca Agrees to Pay $51M in Pay-for-Delay Lawsuit
AstraZeneca PLC has agreed to pay $51 million to settle claims it entered into an unlawful deal to limit competition for antipsychotic drug Seroquel XR. Direct purchaser plaintiffs on Thursday requested preliminary approval of the deal in the US District Court for the District of Delaware, after nearly six years of litigation. “The proposed cash Settlements are in the best interests of the Class, since, if finally approved, the Settlements assur…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
